31 results about "Nutritional Interventions" patented technology

The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.

The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.

The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.

The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.

An early in life nutritional intervention with a lipid component having both large lipid globules with phospholipids and an increased amount of palmitic acid in the sn-2 position in triglycerides werefound to improve the fatty acid composition of cell membranes, in particular brain membranes.

The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.

The invention discloses a clinical nutrition diagnosis and treatment simulation system, which includes an assessment module, a diagnosis module, an intervention module, a monitoring module and an effect evaluation and analysis module. The clinical nutrition diagnosis and treatment simulation system also includes an intelligent database, which includes an assessment database, a diagnosis Database, intervention database, monitoring database; system users can diagnose according to the diagnosis prompts, and the intelligent database is also provided with an intervention database. The intervention database includes a nutrition analysis model, and the analysis model classifies and refines nutrition problems into three-level nutrition problems, Generate intervention information based on the intervention model. The invention provides a clinical nutrition diagnosis and treatment simulation system, which systematizes the implementation of clinical nutrition intervention, and can be used as a training tool for the behavior development of hospital nutrition diagnosis and treatment personnel; accurately limits nutrition problems; the nutrition problem analysis model can be updated to keep up with the latest in the industry Synchronization of research results.

This invention relates to nutritional compositions comprising at least one fucosylated oligosaccharide, preferably 2FL, for use in enhancing the pancreatic development and / or pancreatic maturation of infants, and / or the enhancement of the insulin biosynthesis and / or the prevention of metabolic disorder or associated diseases and / or glucose management during the nutritional intervention or later in life. The composition can be an infant formula. The composition can also comprise at least one N-acetylated oligosaccharide, preferably LnNT.

A nutritional intervention composition for reducing post-prandial blood glucose levels in humans, including between about 0.1 mg and about 10 mg of a proteinase inhibitor that is administered prior to the meal. The composition is effective for treating or ameliorating the effects of hyperglycemia and Type II diabetes. The composition also is effective in combating obesity. The proteinase inhibitor is preferably isolated from plant material, such as potatoes, soy, and beans. Potato proteinase inhibitor II and soybean Bowman-Birk inhibitor are included in the group of effective proteinase inhibitors.